NAMSR News: Medtronic CoreValve U.S. Pivotal Trial results reveal positive outcomes for patients

Medtronic, Inc. (NYSE: MDT) has announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on the Medtronic CoreValve® System.



via Education - Latest News http://www.prlog.org/12235403-namsr-news-medtronic-corevalve-us-pivotal-trial-results-reveal-positive-outcomes-for-patients.html